nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-A2332F18·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.1 Basic medicine·Subfield: Obstetrics and Gynecology·Basis: Full text·Type: Laboratory experiment

Molecular characteristics of established trophoblast-derived cell lines

Jana Pastuschek et al.Jana Pastuschek, Olivia Nonn, Ruby N Gutiérrez-Samudio et al.·2021·Placenta·10.1016/j.placenta.2021.02.022 ↗

Primary claim

In general, characteristics and markers of choriocarcinoma derived cell lines seem to be more similar to in vivo trophoblast than immortalized cell lines and thus might be regarded as more suitable models.

Tentative · literature-referenced marker comparisons without a contemporaneous primary-trophoblast benchmark cannot establish general model suitability
In brief

Seven-line trophoblast profiling identifies overlapping hybridoma genotypes and guides feature-specific model selection, but its general suitability ranking lacks a direct primary-cell benchmark.

ReliabilityCaveats4 of 4 checks completeRead the 3 entries ↓
Possible — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract not available — view at DOI ↗

Key Claims

Primary finding · Tentative

In general, characteristics and markers of choriocarcinoma derived cell lines seem to be more similar to in vivo trophoblast than immortalized cell lines and thus might be regarded as more suitable models.

Possible — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

literature-referenced marker comparisons without a contemporaneous primary-trophoblast benchmark cannot establish general model suitability

Abstract, Discussion
Quote verified
Secondary · Well-supported

STR patterns retrieved from AC1-M32 and ACH-3P cells were 100% identical and differed from AC1 M59 in only one of all 24 tested systems (DE19S433).

matching STR profiles reproduced across passages and an independent ACH-3P batch directly support identity within the tested marker systems

Section 3.3, Table 1
Secondary · Tentative

Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization.

two immortalized lines and undefined functional replicate units limit generalization, while mixed functional rankings contradict the class-wide superiority statement

Abstract (Results); Sections 3.4, 3.6–3.8
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Passage-spanning authentication identifies overlapping hybridoma genotypes

STR profiling across passages and an independent ACH-3P batch identifies matching AC1-M32 and ACH-3P profiles and a one-locus difference from AC1-M59. This provides a concrete basis for scrutinizing the assumed origins of these models.

↳ Sections 2.6 and 3.3; Table 1

#methodological rigour

Complementary assays characterize seven trophoblast models

The comparison combines mRNA, protein, hormone, miRNA and functional measurements rather than relying on a single marker. Assay identifiers, amplification controls and mycoplasma checks support interpretation of the descriptive profiles.

↳ Sections 2.3–2.12 and 3.4–3.8; Figures 2–3

#positioning

Discussion engages conflicting trophoblast marker evidence

The discussion addresses conflicting CK7 and HLA-G reports, culture-dependent phenotypes and omitted models. It explicitly recommends confirmation in primary trophoblast or in vivo before drawing pathophysiological conclusions.

↳ Section 4

Limitations

#reporting

Abstract rankings exceed the reported comparisons

The Discussion places HTR-8/SVneo above BeWo in network nodes, although Results report 105.1 versus 117.3. The abstract also generalizes functional superiority across immortalized lines and overall suitability across choriocarcinoma-derived models despite mixed results and no direct primary-cell benchmark.

↳ Abstract; Sections 3.7–3.8; Section 4; Table 2

#methodological rigour

Wound closure does not isolate migration

The 24-hour closure assay is interpreted as migration even though AC1-M32 and ACH-3P also show higher proliferation. Growth can contribute to closure, preventing a clean migration ranking for those lines.

↳ Sections 2.11 and 3.7; Figure 3A

#methodological rigour

Functional replication and uncertainty remain insufficiently specified

Figure 3 does not establish whether quantitative results summarize independent experiments or technical wells. The absence of inferential testing and dispersion for the reported node counts further limits assessment of functional differences.

↳ Sections 3.7–3.8; Figure 3 legend

Does this match your read? Add your assessment ↓

Nabu Commentary

The main contribution is a multi-assay reference panel anchored by passage-spanning STR authentication and the matching AC1-M32/ACH-3P profiles. Experimental breadth does not resolve the functional comparisons: wound closure mixes migration with proliferation, and Figure 3 leaves quantitative replicate units unclear. The abstract extends feature-specific observations into broader functional and suitability rankings, while the Discussion reverses the reported HTR-8/SVneo–BeWo node comparison. Engagement with conflicting marker literature and explicit calls for primary-cell confirmation provide useful context, but do not establish an overall ranking of trophoblast models.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.2±0.1

Contribution
3.5

The integrated seven-line comparison adds a practical characterization resource, with the matching hybridoma STR profiles providing a specific finding beyond marker compilation. Its advance remains comparative rather than a direct validation against primary trophoblast.

Section 3.3, Table 1; Sections 3.4–3.8; Section 4
Methodological Rigour
2.8

Multi-passage authentication and complementary molecular assays support the descriptive resource, but wound closure does not isolate migration and functional replicate units remain undefined. The reversed HTR-8/SVneo–BeWo node comparison is separately reflected in the Red reliability flag rather than a reliability cap on this score.

Sections 2.6–2.12 and 3.7–3.8; Figures 2–3; Section 4
Reporting
3.1

The progression from authentication to molecular and functional results is followable, and Table 2 provides an accessible synthesis. Abstract generalizations and contradictory descriptions of node rankings, STR uniqueness and assay details reduce precision.

Abstract; Sections 3.3 and 3.6–3.8; Figures 2–3; Table 2; Section 4
Positioning
3.6

The discussion engages conflicting trophoblast-marker reports, culture effects and omitted models, and explicitly requires primary-cell or in-vivo confirmation. Its suitability framework does not fully integrate gestational differences, malignant background and research-question-specific marker weighting.

Introduction; Section 4; Table 2

Lower confidence on Methodological Rigour — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization: "Conversely, they express C14MC and exhibit higher migration and network stabilization." (Abstract; Section 3.7, migration) vs "Swan71, ACH-3P and AC1-M32 showed a noticeably higher migration potential with faster closure rates compared to the other tested cell lines." (Section 3.7). The Results identify one immortalized line, Swan71, and two hybridoma lines as faster closing, rather than both immortalized lines. → Changes the size materially
  • Network stabilization properties in co-culture with endothelial cells revealed higher node building numbers in Swan71 and HTR-8/SVneo cells than in JEG-3 and BeWo cells: "Network stabilization properties in co-culture with endothelial cells revealed higher node building numbers in Swan71 and HTR-8/SVneo cells than in JEG-3 and BeWo cells." (Section 4, network stabilization discussion) vs "Swan71 cells showed the highest number of nodes (141.6) followed by BeWo, HTR-8/SVneo and JEG-3 cells (117.3, 105.1 and 100.8, respectively)." (Section 3.8). HTR-8/SVneo has 105.1 − 117.3 = −12.2 nodes relative to BeWo, contradicting the stated higher-node comparison. → Not supported by the paper's own data
  • Immortalized cell lines differ from choriocarcinoma-derived ones in the expression of HLA-G, E-cadherin, N-cadherin, VE-cadherin, cadherin-11, cytokeratin 7, vimentin, ADAM12 and PRG2: "Vimentin and N-cadherin were exclusively expressed in HTR-8/SVneo and Swan71 cells." (Section 3.5, vimentin and N-cadherin) vs "only in low levels by BeWo (vimentin) and the AC1-M32, AC1-M59 and ACH-3P cell lines (N-cadherin)" (Section 4, mesenchymal markers paragraph). The Discussion reports low expression outside the two immortalized lines, contradicting exclusivity but not the broader expression contrast. → Conclusion holds
  • Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization: "Cell migration was assessed using Ibidi™ culture inserts" (Section 2.11, migration assay) vs "were tested using the xCELLigence® Real-Time Cell Analyzer system" (Fig. 3A legend). Methods specify an insert-based wound-healing assay, whereas the Figure 3A caption attributes migration to xCELLigence. → Effect on result unclear
  • Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization: "C14MC (has-miR-127–3p, assay ID: 477889_mir; has-miR-411–5p, Assay ID: 478086_mir; has-miR-655–3p, Assay ID: 478191_mir)" (Section 2.7) vs "Swan71 cells expressed high levels of all five tested C14MC miRNAs, while in HTR-8/SVneo cells only three miRNAs were detected at lower levels." (Section 3.6). Methods enumerate three C14MC assays, whereas Results refer to five tested C14MC miRNAs. → Conclusion holds
Reporting and transparencyNoted

The secondary-antibody list does not account for the reported rabbit primary antibodies. A conflict-of-interest declaration is present, and the established-cell-line design does not require a new human or animal ethics approval.

Conflict of interest: declared · Data availability: not stated · Code availability: not stated

Reference IntegrityNoted

76 references in manuscript 74 of 76 checkable references found in an index 8 mistyped DOIs matched to the cited work by its details

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceEmpirical
Route to useNamed
AdvanceExtends
CitationsFWCI 8.0
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The comparative claim rests on systematic qPCR, immunoblotting, hormone, miRNA and functional assays run under controlled in vitro laboratory conditions, with no independent or in vivo confirmation.

From the paper
“This will help placenta researchers in the selection of cell lines for an appropriate experimental use”

The paper names placenta researchers as the actors who would use these findings to choose cell lines for experiments, but does not specify a concrete decision setting beyond that.

Pathway

Placenta researchers would use this marker and function catalogue to select the most appropriate trophoblast cell line per research question, improving the relevance of studies on placental development and pathology.

Barrier

The findings are entirely in vitro, and the authors themselves stress that cell-line data must be confirmed in primary trophoblasts or in vivo before pathophysiological conclusions can be drawn.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia

    Olivia Nonn, Cornelius Fischer, Sabrina Geisberger, et al. · 2021 · Basic medicine

    Primary claim

    Ang IV decreases trophoblastic mitochondrial respiration and increases placental leptin via placental LNPEP.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. Placental physioxia is based on spatial and temporal variations of placental oxygenation throughout pregnancy

    Berthold Huppertz · 2023 · Basic medicine

    Primary claim

    In early-onset preeclampsia cases, all in vivo data available today point to increased oxygen values in the intervillous space of the placenta.

    Tentative
    Evidence Score
    2.4±0.2
    Reliability
    Caveats
  3. Maternal platelets at the first trimester maternal-placental interface - Small players with great impact on placenta development

    Jacqueline Guettler, Désirée Forstner, Martin Gauster · 2021 · Basic medicine

    Primary claim

    In normal early human pregnancy, maternal platelets may contribute to placenta development by acting on both the extravillous- and the villous trophoblast compartment.

    Tentative
    Evidence Score
    3.1±0.1
    Reliability
    Caveats

How the rubric works →